A low molecular weight heparin used for the prevention and treatment of deep-vein thrombosis and for the prevention of blood clots in patients undergoing kidney dialysis. It is available as a solution for subcutaneous injection on prescription only.
WisMed Pharma is dedicated to research, develop, and produce the newest pharmaceutical ingredients. We are capable to conduct independent researches and synthesis new chemical entities. Our areas of focus include cardio cerebral vascular, anticancer and anti-aging. Our R&D on saccharide products is superior. With strict quality management systems, and complete sets of analysis instruments, all of our products bear money-back-guarantees. Our R&D center has written a number of independent intellec...
View more >>
Basic Information
Business Type: Manufacturer
Product/Service (We Buy): 51 - 100 People
Ownership Type: LLC (Ltd Liability Corp)
Registered Capital: US$5 Million - US$10 Million
Year Established: 2011
Number of Employees: 51 - 100 People
Trade & Market
Main Markets: North America,South America,Eastern Europe,Western Europe
QA/QC: In House
Number of Production Lines: 5
Number of R&D Staff: 97
Number of QC Staff: 5 - 10 People
Total Annual Sales Volume: US$10 Million - US$50 Million
China![CAS No:91449-79-5 (4S,6R)-6-[(2R,4R)-4,<br />6-dihydroxy-5-(sulfonatoamino)-2-(sulfonatooxymethyl)oxan-3-yl]oxy-3,<br />4-dihydroxy-5-sulfonatooxyoxane-2-carboxylate](/structure/cas-914/91449-79-5.png)